AstraZeneca Gets Diagnostics Infusion With Roche, Qiagen Lung Cancer Deals
This article was originally published in The Pink Sheet Daily
Executive Summary
The pure pharma taps Roche’s diagnostics expertise to develop a companion blood-based test for candidate AZD9291, and enlists Qiagen to develop a non-invasive diagnostic for Iressa in non-small cell lung cancer.